Phathom Pharmaceuticals, Inc. (PHAT)

NASDAQ: PHAT · Real-Time Price · USD

9.59

-0.73 (-7.07%)

At close: May 29, 2026, 4:00 PM EDT

9.55

-0.04 (-0.42%)

After-hours: May 29, 2026, 7:56 PM EDT

Phathom Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	204.89	175.11	55.25	0.68	-	-
Revenue Growth (YoY)	150.30%	216.93%	8001.47%	-	-	-
Cost of Revenue	30.87	22.6	7.97	0.17	-	-
Gross Profit	174.02	152.51	47.28	0.52	-	-
Selling, General & Admin	239.25	279.72	290.66	117.93	101	62.74
Research & Development	31.37	32.78	34.08	49.9	71.44	72.34
Total Operating Expenses	270.62	312.5	324.75	167.83	172.44	135.08
Operating Income	-96.6	-159.99	-277.47	-167.31	-172.44	-135.08
Interest Income	6.14	7.04	15.16	7.88	2.13	0.04
Interest Expense	-65.84	-68.12	-72.01	-41.97	-27.31	-6.79
Other Non-Operating Income (Expense)	-1	-0.19	-0.01	-0.19	-0.11	-2.06
Total Non-Operating Income (Expense)	-60.7	-61.26	-56.86	-34.28	-25.28	-8.8
Pretax Income	-157.3	-221.25	-334.33	-201.59	-197.72	-143.88
Net Income	-157.3	-221.25	-334.33	-201.59	-197.72	-143.88
Net Income to Common	-157.3	-221.25	-334.33	-201.59	-197.72	-143.88
Shares Outstanding (Basic)	75	73	63	51	39	37
Shares Outstanding (Diluted)	75	73	63	51	39	37
Shares Change (YoY)	13.35%	15.42%	23.18%	31.11%	5.72%	11.36%
EPS (Basic)	-2.12	-3.03	-5.29	-3.93	-5.05	-3.89
EPS (Diluted)	-2.12	-3.03	-5.29	-3.93	-5.05	-3.89
Shares Outstanding	79.44	71.42	68.52	57.97	41.47	30.51
Free Cash Flow	-97.76	-167	-266.91	-139.21	-147.57	-148.79
Free Cash Flow Per Share	-1.30	-2.29	-4.22	-2.71	-3.77	-4.02
Gross Margin	84.93%	87.09%	85.57%	75.51%	-	-
Operating Margin	-47.15%	-91.36%	-502.18%	-24532.60%	-	-
Profit Margin	-76.77%	-126.35%	-605.09%	-29558.90%	-	-
FCF Margin	-47.71%	-95.37%	-483.07%	-20412.60%	-	-
EBITDA	-96.03	-159.35	-276.67	-166.74	-171.82	-134.56
EBITDA Margin	-46.87%	-91.00%	-500.75%	-24448.20%	-	-
EBIT	-96.6	-159.99	-277.47	-167.31	-172.44	-135.08
EBIT Margin	-47.15%	-91.36%	-502.18%	-24532.60%	-	-

SEC Filings: 10-K · 10-Q